Lincocin

Lincomycin, the active ingredient in Lincocin, is a lincosamide antibiotic presented as an injection for intramuscular and intravenous use. It treats susceptible bacterial infections, including skin and soft‑tissue, bone and joint, and intra‑abdominal infections, in adult and pediatric patients as determined by a prescriber.

GNH USA supplies Lincocin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lincomycin is used to treat infections caused by susceptible bacteria, primarily targeting Gram‑positive organisms and certain anaerobes.

- Skin and soft‑tissue infections: effective against cellulitis, abscesses, and wound infections caused by susceptible strains. - Bone and joint infections: used for osteomyelitis and septic arthritis when the pathogen is susceptible. - Intra‑abdominal infections: employed in treatment of peritonitis and intra‑abdominal abscesses caused by susceptible organisms.

Lincomycin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools, often self‑limited. - Injection site pain: local discomfort or erythema. - Rash: mild skin eruption. - Elevated liver enzymes: transient increase in hepatic transaminases.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Stevens‑Johnson syndrome: rare but life‑threatening skin disorder. - Clostridioides difficile colitis: severe intestinal infection. - Hepatotoxicity: significant liver injury with jaundice. - Hematologic abnormalities: neutropenia or thrombocytopenia.

When using Lincomycin, clinicians should consider several safety and handling precautions. - Allergy assessment: verify no known hypersensitivity to lincosamides or lincomycin. - Renal function: adjust or monitor in patients with impaired kidney function. - Hepatic function: monitor liver enzymes during prolonged therapy. - Concomitant antibiotics: avoid use with clindamycin unless susceptibility is confirmed. - Pregnancy and lactation: use only if the potential benefit outweighs risk, as safety data are limited. - Store at 2‑8 °C: keep refrigerated, protect from light, do not freeze or shake.

Lincomycin can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Neuromuscular blockers: may potentiate blockade, increasing risk of respiratory depression. - Erythromycin: competitive inhibition at the bacterial ribosome can reduce effectiveness of both agents.

Moderate Interactions (Monitor Closely): - Warfarin: may enhance anticoagulant effect, requiring INR monitoring. - Carbapenems (e.g., imipenem): antagonistic effect reducing antibacterial activity. - Oral contraceptives: possible reduction in efficacy, advise additional contraceptive measures. - Probenecid: may decrease renal clearance of lincomycin, increasing plasma levels.